Platelet-derived growth factor: a key factor in the pathogenesis of graves' ophthalmopathy and potential target for treatment.
Virakul, Sita; van Steensel, Leendert; Dalm, Virgil A S H; Paridaens, Dion; van Hagen, P Martin; Dik, Willem A.
Eur Thyroid J
; 3(4): 217-26, 2014 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-25759797
The tyrosine kinase inhibitor dasatinib effectively blocks PDGF-induced orbital fibroblast activation.
PDGF enhances orbital fibroblast responses to TSHR stimulating autoantibodies in Graves' ophthalmopathy patients.
Diverse effects of platelet-derived growth factor-BB on cell signaling pathways.
Platelet-Derived Growth Factor-BB Enhances Adipogenesis in Orbital Fibroblasts.
Basic Fibroblast Growth Factor Induces Adipogenesis in Orbital Fibroblasts: Implications for the Pathogenesis of Graves' Orbitopathy.
Basic FGF and PDGF-BB synergistically stimulate hyaluronan and IL-6 production by orbital fibroblasts.
Hypoxia promotes osteosarcoma cell proliferation and migration through enhancing platelet-derived growth factor-BB/platelet-derived growth factor receptor-ß axis.
Current perspectives on the role of orbital fibroblasts in the pathogenesis of Graves' ophthalmopathy.
ETS variant 5 promotes colorectal cancer angiogenesis by targeting platelet-derived growth factor BB.
Transgenic Silkworm-Based Silk Gland Bioreactor for Large Scale Production of Bioactive Human Platelet-Derived Growth Factor (PDGF-BB) in Silk Cocoons.